 |
 |
 |
 |
 |
 |
 |
 |
 |
CombinatoRx, Incorporated
CombinatoRx (NASD:CRXX) is a biopharmaceutical company pioneering a systems biology approach to create new combination medicines that attack inflammatory and metabolic diseases on multiple fronts. CombinatoRx went public in November 2005.